By Drug Target Review2025-01-24T08:00:01
UVA researchers found that continuous glucose monitor data can predict nerve, eye, and kidney damage in type 1 diabetes.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2023-11-24T12:06:45
Sponsored by Quantum-Si
2023-05-31T15:16:10
Sponsored by Bio-Techne
2023-09-27T13:56:39
Sponsored by Euretos
2025-05-08T10:38:52
Sponsored by Takara Bio USA
2024-01-24T12:52:38
Sponsored by BellBrook Labs
Site powered by Webvision Cloud